Two new triterpenoid glucosides, Heritiera A () and Heritiera B (), and six known triterpenoid analogs (-) were isolated from Dryand. Their structures were identified by comprehensive spectroscopic analyses and comparisons with the literature. The anti-inflammatory activity of the isolates from was evaluated using a lipopolysaccharide (LPS) stimulated RAW 264.7 cells model. The result showed that four triterpenoids exhibited potent anti-inflammatory activity. Among these compounds, compound substantially inhibits the release of nitric oxide (NO) with an IC value of 10.33 μM. The triterpenoids from could be used as potential candidates for the development of new anti-inflammatory agents.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959541PMC
http://dx.doi.org/10.3390/molecules28041658DOI Listing

Publication Analysis

Top Keywords

triterpenoid glucosides
8
anti-inflammatory activity
8
discovery anti-inflammatory
4
anti-inflammatory triterpenoid
4
glucosides dryand
4
dryand triterpenoid
4
glucosides heritiera
4
heritiera heritiera
4
heritiera triterpenoid
4
triterpenoid analogs
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!